Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, nanotech investing specialist Harris & Harris
With that in mind, let's take a closer look at Harris & Harris' business and see what CAPS investors are saying about the stock right now.
Harris & Harris facts
|Headquarters (Founded)||New York (1981)|
|Market Cap||$157.2 million|
|Management||Chairman/CEO Douglas Jamison
CFO/COO Dr. Daniel Wolfe
|Return on Equity (Average, Past 3 Years)||(10.8%)|
|Cash/Debt||$3.76 million / $0|
Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.
Just last month, Zemko100 described Harris & Harris in a purely positive light:
Venture capital group well positioned in a number of companies primarily involved with some aspect of nanotechnology. Very smart guys leading this parade. Sector diversification by people with real skin in the game.
Currently, Harris & Harris even sports a cheapish price-to-book ratio of 1.1. That represents a clear discount to much larger private-equity plays, such as Blackstone Group
CAPS member Writerjeff2 elaborates on the bull case:
Harris & Harris is a company that invests in start-up companies in nano-technology. The stock has been hurt by the recession and general absence of M&A activity in the technology sector. As the business climate improves TINY should see opportunity to cash in on some of its investments. Case in point: their portfolio company BioVex [was] acquired by Amgen. I expect to see more of this in the next two to four years.
What do you think Harris & Harris, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!